We are monitoring the impact of COVID-19 on Europe Companion Diagnostics Market Get in touch with us for detailed analysis Know More
Share on

Europe Companion Diagnostics Market Research Report – Segmented By Indication, By Technology & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2022 to 2027)

Published: January, 2022
ID: 590
Pages: 145

Europe Companion Diagnostics Market Size (2022 to 2027)

As per the report, the size of the Companion Diagnostics Market in Europe was worth USD 1.1 billion in 2022 and estimated to be growing at a CAGR of 20.66%, to reach USD 2.81 billion by 2027.

The growing popularity of improving treatment procedures by properly analyzing diagnosis data and the growing number of targeted medicines, and the shift toward individualized medicine drive the companion diagnostics market in Europe.

Furthermore, a growing focus on next-generation sequencing technology and diagnostic procedures substantially impacts pharmaceutical development, which could stifle the expansion of the European companion diagnostics market.

Furthermore, with the help of private and public organizations, the market's growth rate is boosted by an increasing number of diagnostic centers with cutting-edge equipment and rising healthcare spending. Companion diagnostics also promotes improved treatment options for a specific ailment that are more appropriate for the patient, so boosting the companion diagnostics business in Europe.

As the number of COVID-19 cases grew, researchers concentrated their efforts on learning more about the virus and the symptoms it produced. Furthermore, the growing importance of companion diagnostics in drug discovery and the growing number of clinical investigations for potential medicinal therapy drive demand for companion diagnostics during COVID-19. Companion diagnostics are useful in clinical trials because they help researchers discover biomarkers and disease-specific therapy targets. As a result, market growth is expected to accelerate during the forecast period.

The lack of awareness and qualified specialists and the expense of installing and maintaining the technology necessitates large sums of money those small businesses cannot pay, which are expected to be stifling the growth of the companion diagnostics market in the European region. Frequent software updates and the time it takes to upgrade an existing one cost a little more. This characteristic is limiting the market's demand. Furthermore, the business has been hampered by a scarcity of experienced specialists to fix problems in real-time applications. During the first quarter of 2020, the European companion diagnostics market was negatively impacted by the pandemic, which has been declared a healthcare emergency by the WHO. When the epidemic spread quickly, all countries declared a state of emergency. A limitation on planes and transportation has a huge impact on the European companion diagnostics market.

This research report on the Europe Companion Diagnostics Market has been segmented and sub-segmented into the following categories:

By Indications:

  • Oncology
    • Colorectal Cancer
    • Lung Cancer
    • Breast Cancer
    • Gastric Cancer
    • Melanoma
  • Inflammation and Autoimmune Diseases
  • Cardiovascular Diseases
  • Central Nervous System Disorders
  • Virology Diseases

By Technology:

  • Immunohistochemistry
  • Molecular Diagnostics
    • In-Situ Hybridization
    • Real-Time PCR
    • Gene Sequencing

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Europe was the second-largest regional market globally for companion diagnostics in 2020. During the forecast period, the market's growth is also expected to be fuelled by increasing the number of patients suffering from various ailments such as cancer, heart disease, and others. In addition, the market's demand is being fuelled by a growing understanding of how to launch companion diagnostic procedures for various applications. As a result, EU countries such as the United Kingdom, Germany, and France are expected to have the largest market share in Europe during the projection period.

Improved efficacy/safety profiles of pharmaceuticals expedited drug regulatory approvals, lower healthcare expenditure, drug research costs, and increased partnerships between market companies and government agencies are further estimated to drive the European market during the forecast period.

Between 2022 and 2027, the United Kingdom will dominate the Europe Companion Diagnostics market. The growing importance of customized medicine and the co-development of therapeutic and diagnostic technologies can be ascribed to the expansion of the companion diagnostics market. In addition, the necessity for companion diagnostics is growing due to an increase in the number of cases of adverse medication responses.

Germany is expected to hold a substantial proportion of the European Companion Diagnostics market, following the United Kingdom. The companion diagnostics market is predicted to grow significantly over the forecast period, owing to increased targeted therapy research and development and a demand for personalized medication.

KEY MARKET PLAYERS:

A few of the promising companies operating in the Europe Companion Diagnostics Market profiled in this report are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc., Biogenex Laboratories Inc., Ventana Medical Systems Inc., and Thermo Fisher Scientific Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Indications                            

                                5.1.1 Oncology 

                                                5.1.1.1 Colorectal Cancer

                                                5.1.1.2 Breast Cancer

                                                5.1.1.3 Lung Cancer

                                                5.1.1.4 Gastric Cancer

                                                5.1.1.5 Melanoma

                                5.1.2 Inflammation and Autoimmune Diseases  

                                5.1.3 Cardiovascular Diseases    

                                5.1.4 Central Nervous System Disorders               

                                5.1.5 Virology Diseases 

                5.2 By Technology                           

                                5.2.1 Immuno Histochemistry    

                                5.2.2 Molecular Diagnostics        

                                                5.2.2.1 In-Situ Hybridization

                                                5.2.2.2 Real Time PCR

                                                5.2.2.3 Gene Sequencing

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 U.K 

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Molecular Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Roche Molecular Systems Inc.                            

                8.3 Leica Biosystems Nussloch GmbH                     

                8.4 BioMérieux Inc.                        

                8.5 Dako Inc.                     

                8.6 Qiagen Ltd.                 

                8.7 ARUP Laboratories                  

                8.8 Myriad Genetics Inc.                              

                8.9 Biogenex Laboratories, Inc.                 

                8.10 Ventana Medical Systems Inc.                         

                8.11 Thermo Fisher Scientific Inc.                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Europe Companion Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  2. Europe Companion Diagnostics Market By Indication, From 2022 - 2027 (USD Billion)
  3. Europe Oncology Market By Region, From 2022 - 2027 (USD Billion)
  4. Europe Inflammation and Autoimmune Diseases Market By Region, From 2022 - 2027 (USD Billion)
  5. Europe Cardiovascular Diseases Market By Region, From 2022 - 2027 (USD Billion)
  6. Europe Central Nervous System Disorders Market By Region, From 2022 - 2027 (USD Billion)
  7. Europe Virology Diseases Market By Region, From 2022 - 2027 (USD Billion)
  8. Europe Companion Diagnostics Market By Technology, From 2022 - 2027 (USD Billion)
  9. Europe Immuno Histochemistry Market By Region, From 2022 - 2027 (USD Billion)
  10. Europe Molecular Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  11. Europe Oncology Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  12. Europe Colorectal Cancer Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  13. Europe Breast Cancer Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  14. Europe Lung Cancer Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  15. Europe Gastric Cancer Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  16. Europe Melanoma Diagnostics Market By Region, From 2022 - 2027 (USD Billion)
  17. Europe Molecular Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  18. Europe In-Situ Hybridization Market By Region, From 2022 - 2027 (USD Billion)
  19. Europe Real Time PCR Market By Region, From 2022 - 2027 (USD Billion)
  20. Europe Gene Sequencing Market By Region, From 2022 - 2027 (USD Billion)
  21. U.K Companion Diagnostics Market By Indication, From 2022 - 2027 (USD Billion)
  22. U.K Companion Diagnostics Market By Technology, From 2022 - 2027 (USD Billion)
  23. U.K Oncology Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  24. U.K Molecular Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  25. Spain Companion Diagnostics Market By Indication, From 2022 - 2027 (USD Billion)
  26. Spain Companion Diagnostics Market By Technology, From 2022 - 2027 (USD Billion)
  27. Spain Oncology Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  28. Spain Molecular Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  29. Germany Companion Diagnostics Market By Indication, From 2022 - 2027 (USD Billion)
  30. Germany Companion Diagnostics Market By Technology, From 2022 - 2027 (USD Billion)
  31. Germany Oncology Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  32. Germany Molecular Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  33. Italy Companion Diagnostics Market By Indication, From 2022 - 2027 (USD Billion)
  34. Italy Companion Diagnostics Market By Technology, From 2022 - 2027 (USD Billion)
  35. Italy Oncology Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  36. Italy Molecular Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  37. France Companion Diagnostics Market By Indication, From 2022 - 2027 (USD Billion)
  38. France Companion Diagnostics Market By Technology, From 2022 - 2027 (USD Billion)
  39. France Oncology Diagnostics Market By Type, From 2022 - 2027 (USD Billion)
  40. France Molecular Diagnostics Market By Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample